Reata Pharmaceuticals Inc... (RETA)
NASDAQ: RETA
· Real-Time Price · USD
172.36
0.04 (0.02%)
At close: Sep 25, 2023, 10:00 PM
Reata Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -87.62M | -354.18M | -311.9M | -311.78M | -304.63M | -303.77M | -297.39M | -277.78M | -271.39M | -266.27M |
Depreciation & Amortization | 1.13M | 1.11M | 1.13M | 1.18M | 1.22M | 1.24M | 1.2M | 1.17M | 1.14M | 1.13M |
Stock-Based Compensation | 87.84M | 81.34M | 58.73M | 58.98M | 58.19M | 57.57M | 56.81M | 53.53M | 51.45M | 53.01M |
Other Working Capital | 9.16M | 6.88M | 4.11M | -74M | -73.8M | -54.95M | -58.29M | 20.78M | 16.73M | -161.36M |
Other Non-Cash Items | 34.44M | 37.66M | 38.46M | 43.24M | 47.21M | 50.48M | 53.25M | 51.67M | 49.16M | 51.48M |
Deferred Income Tax | -291.96M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.18M |
Change in Working Capital | 7.84M | 6.53M | 9.31M | -68.38M | -74.39M | -54.39M | -49.58M | 13.51M | 13.8M | -165.52M |
Operating Cash Flow | -248.34M | -227.53M | -204.27M | -276.77M | -272.4M | -248.88M | -235.7M | -157.91M | -155.84M | -326.18M |
Capital Expenditures | -1.12M | -3.12M | -3.27M | -3.1M | -3.43M | -1.42M | -1.33M | -1.52M | -1M | -1.03M |
Cash Acquisitions | 75M | 75M | 75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -631.88M | -725.76M | -661.89M | -477.77M | -333.97M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 617.42M | 420M | 245M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 75M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 59.42M | -233.88M | -345.16M | -405.86M | -337.4M | -1.42M | -1.33M | -1.52M | -1M | -1.03M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 22.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 13.83M | 14.37M | 1.49M | 1.34M | 1.24M | 702K | 5.19M | 290.43M | 298.19M | 480.35M |
Financial Cash Flow | 90.61M | 14.37M | 1.49M | 1.34M | 1.24M | 4.65M | 9.14M | 294.38M | 302.14M | 480.35M |
Net Cash Flow | -98.31M | -447.04M | -547.95M | -681.29M | -608.55M | -245.65M | -227.89M | 134.95M | 145.29M | 153.14M |
Free Cash Flow | -249.46M | -230.65M | -207.54M | -279.87M | -275.83M | -250.3M | -237.03M | -159.43M | -156.85M | -327.21M |